In patients with IgE‐mediated food allergy eligible for allergen‐specific immunotherapy, its administration is recommended under the guidance of a clinical team with experience in food immunotherapy and in managing its side effects and anaphylaxis. This evidence concerns the gene IGHE and food allergy.